A pilot study of D-cycloserine in subjects with autistic disorder

David J. Posey, Deborah L. Kem, Naomi Swiezy, Thayne L. Sweeten, Ryan E. Wiegand, Christopher J. McDougle

Research output: Contribution to journalArticle

135 Citations (Scopus)

Abstract

Objective: The authors assessed the effects of D-cycloserine on the core symptom of social impairment in subjects with autism. Method: Following a 2-week, single-blind placebo lead-in phase, drug-free subjects with autistic disorder were administered three different doses of D-cycloserine during each of three 2-week periods. Measures used for subject ratings included the Clinical Global Impression (CGI) scale and Aberrant Behavior Checklist. Results: Significant improvement was found on the CGI and social withdrawal subscale of the Aberrant Behavior Checklist. D-Cycloserine was well tolerated at most of the doses used in this study. Conclusions: In this pilot study, D-cycloserine treatment resulted in significant improvement in social withdrawal. Further controlled studies of D-cycloserine in autism appear warranted.

Original languageEnglish (US)
Pages (from-to)2115-2117
Number of pages3
JournalAmerican Journal of Psychiatry
Volume161
Issue number11
DOIs
StatePublished - Nov 2004
Externally publishedYes

Fingerprint

Cycloserine
Autistic Disorder
Checklist
Placebos
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Posey, D. J., Kem, D. L., Swiezy, N., Sweeten, T. L., Wiegand, R. E., & McDougle, C. J. (2004). A pilot study of D-cycloserine in subjects with autistic disorder. American Journal of Psychiatry, 161(11), 2115-2117. https://doi.org/10.1176/appi.ajp.161.11.2115

A pilot study of D-cycloserine in subjects with autistic disorder. / Posey, David J.; Kem, Deborah L.; Swiezy, Naomi; Sweeten, Thayne L.; Wiegand, Ryan E.; McDougle, Christopher J.

In: American Journal of Psychiatry, Vol. 161, No. 11, 11.2004, p. 2115-2117.

Research output: Contribution to journalArticle

Posey, DJ, Kem, DL, Swiezy, N, Sweeten, TL, Wiegand, RE & McDougle, CJ 2004, 'A pilot study of D-cycloserine in subjects with autistic disorder', American Journal of Psychiatry, vol. 161, no. 11, pp. 2115-2117. https://doi.org/10.1176/appi.ajp.161.11.2115
Posey, David J. ; Kem, Deborah L. ; Swiezy, Naomi ; Sweeten, Thayne L. ; Wiegand, Ryan E. ; McDougle, Christopher J. / A pilot study of D-cycloserine in subjects with autistic disorder. In: American Journal of Psychiatry. 2004 ; Vol. 161, No. 11. pp. 2115-2117.
@article{d8775f3d40754de5ba70c9d389806b71,
title = "A pilot study of D-cycloserine in subjects with autistic disorder",
abstract = "Objective: The authors assessed the effects of D-cycloserine on the core symptom of social impairment in subjects with autism. Method: Following a 2-week, single-blind placebo lead-in phase, drug-free subjects with autistic disorder were administered three different doses of D-cycloserine during each of three 2-week periods. Measures used for subject ratings included the Clinical Global Impression (CGI) scale and Aberrant Behavior Checklist. Results: Significant improvement was found on the CGI and social withdrawal subscale of the Aberrant Behavior Checklist. D-Cycloserine was well tolerated at most of the doses used in this study. Conclusions: In this pilot study, D-cycloserine treatment resulted in significant improvement in social withdrawal. Further controlled studies of D-cycloserine in autism appear warranted.",
author = "Posey, {David J.} and Kem, {Deborah L.} and Naomi Swiezy and Sweeten, {Thayne L.} and Wiegand, {Ryan E.} and McDougle, {Christopher J.}",
year = "2004",
month = "11",
doi = "10.1176/appi.ajp.161.11.2115",
language = "English (US)",
volume = "161",
pages = "2115--2117",
journal = "American Journal of Psychiatry",
issn = "0002-953X",
publisher = "American Psychiatric Association",
number = "11",

}

TY - JOUR

T1 - A pilot study of D-cycloserine in subjects with autistic disorder

AU - Posey, David J.

AU - Kem, Deborah L.

AU - Swiezy, Naomi

AU - Sweeten, Thayne L.

AU - Wiegand, Ryan E.

AU - McDougle, Christopher J.

PY - 2004/11

Y1 - 2004/11

N2 - Objective: The authors assessed the effects of D-cycloserine on the core symptom of social impairment in subjects with autism. Method: Following a 2-week, single-blind placebo lead-in phase, drug-free subjects with autistic disorder were administered three different doses of D-cycloserine during each of three 2-week periods. Measures used for subject ratings included the Clinical Global Impression (CGI) scale and Aberrant Behavior Checklist. Results: Significant improvement was found on the CGI and social withdrawal subscale of the Aberrant Behavior Checklist. D-Cycloserine was well tolerated at most of the doses used in this study. Conclusions: In this pilot study, D-cycloserine treatment resulted in significant improvement in social withdrawal. Further controlled studies of D-cycloserine in autism appear warranted.

AB - Objective: The authors assessed the effects of D-cycloserine on the core symptom of social impairment in subjects with autism. Method: Following a 2-week, single-blind placebo lead-in phase, drug-free subjects with autistic disorder were administered three different doses of D-cycloserine during each of three 2-week periods. Measures used for subject ratings included the Clinical Global Impression (CGI) scale and Aberrant Behavior Checklist. Results: Significant improvement was found on the CGI and social withdrawal subscale of the Aberrant Behavior Checklist. D-Cycloserine was well tolerated at most of the doses used in this study. Conclusions: In this pilot study, D-cycloserine treatment resulted in significant improvement in social withdrawal. Further controlled studies of D-cycloserine in autism appear warranted.

UR - http://www.scopus.com/inward/record.url?scp=7444237570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=7444237570&partnerID=8YFLogxK

U2 - 10.1176/appi.ajp.161.11.2115

DO - 10.1176/appi.ajp.161.11.2115

M3 - Article

VL - 161

SP - 2115

EP - 2117

JO - American Journal of Psychiatry

JF - American Journal of Psychiatry

SN - 0002-953X

IS - 11

ER -